For the onset from the COVID-19 pandemic, Corbett begun focusing on a vaccine to shield people from coronavirus disorder.[3] Recognizing the virus was just like severe acute respiratory syndrome coronavirus, Corbett's staff utilized preceding expertise in optimum coronavirus proteins to tackle COVID